Invasive pneumococcal disease in adults after the introduction of pneumococcal vaccination: a retrospective study in the metropolitan area of Zagreb, Croatia (2010–2022)
2024

Impact of Pneumococcal Vaccination on Invasive Pneumococcal Disease in Adults

Sample size: 389 publication Evidence: high

Author Information

Author(s): Čivljak Rok, Draženović Karla, Butić Iva, Kljaković Gašpić Batinjan Marina, Huljev Eva, Vicković Ninoslava, Lizatović Ivan Krešimir, Grgić Borna, Budimir Ana, Janeš Andrea, Nikić Hecer Ana, Filipec Kanižaj Tajana, Tešić Vanja, Kosanović Ličina Mirjana Lana, Dobrović Karolina

Primary Institution: University Hospital for Infectious Diseases “Dr. Fran Mihaljević”, Zagreb, Croatia

Hypothesis

Did the introduction of pneumococcal vaccination influence the incidence and mortality of invasive pneumococcal disease in adults in Croatia?

Conclusion

The introduction of pneumococcal vaccination has led to a significant decrease in the incidence and mortality of invasive pneumococcal disease in adults.

Supporting Evidence

  • 389 patients were hospitalized for invasive pneumococcal disease during the study period.
  • 64% of patients had an indication for vaccination, but only 4.4% were vaccinated.
  • The incidence of invasive pneumococcal disease decreased from 4.1/100,000 in 2011 to 0.6/100,000 in 2022.
  • 16.5% of patients died from invasive pneumococcal disease during the study.
  • 85.1% of patients had at least one risk factor for developing invasive pneumococcal disease.

Takeaway

This study found that giving adults a vaccine can help them avoid a serious illness called invasive pneumococcal disease, which can make them very sick or even lead to death.

Methodology

A retrospective study was conducted among adult patients hospitalized due to invasive pneumococcal disease in Zagreb from 2010 to 2022.

Limitations

The study only included adults from Zagreb and did not assess the impact of vaccination on children.

Participant Demographics

The median age of participants was 63 years, with 55.5% male and 47.6% aged 65 or older.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI 1.70–139.73 for hypogammaglobulinemia; 95% CI 9.45–616.37 for asplenia; 95% CI 1.83–57.76 for CNS trauma

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.3389/fpubh.2024.1480348

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication